AGILENT TECHNOLOGIES INC (A)

US00846U1016 - Common Stock

134.51  +1.32 (+0.99%)

After market: 134.51 0 (0%)

Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to A. A was compared to 56 industry peers in the Life Sciences Tools & Services industry. Both the health and profitability get an excellent rating, making A a very profitable company, without any liquidiy or solvency issues. A has a valuation in line with the averages, but it does not seem to be growing.



8

1. Profitability

1.1 Basic Checks

A had positive earnings in the past year.
A had a positive operating cash flow in the past year.
A had positive earnings in 4 of the past 5 years.
A had a positive operating cash flow in 4 of the past 5 years.

1.2 Ratios

With an excellent Return On Assets value of 12.85%, A belongs to the best of the industry, outperforming 92.86% of the companies in the same industry.
A's Return On Equity of 23.94% is amongst the best of the industry. A outperforms 96.43% of its industry peers.
A has a Return On Invested Capital of 15.02%. This is amongst the best in the industry. A outperforms 92.86% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for A is above the industry average of 9.98%.
The last Return On Invested Capital (15.02%) for A is above the 3 year average (14.34%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 12.85%
ROE 23.94%
ROIC 15.02%
ROA(3y)11.58%
ROA(5y)10.71%
ROE(3y)22.44%
ROE(5y)20.92%
ROIC(3y)14.34%
ROIC(5y)12.54%

1.3 Margins

A has a better Profit Margin (21.75%) than 100.00% of its industry peers.
A's Profit Margin has improved in the last couple of years.
A has a better Operating Margin (24.70%) than 94.64% of its industry peers.
A's Operating Margin has improved in the last couple of years.
A's Gross Margin of 54.75% is fine compared to the rest of the industry. A outperforms 69.64% of its industry peers.
A's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 24.7%
PM (TTM) 21.75%
GM 54.75%
OM growth 3Y8.56%
OM growth 5Y2.16%
PM growth 3Y10.45%
PM growth 5Y23.06%
GM growth 3Y-1.44%
GM growth 5Y-1.41%

7

2. Health

2.1 Basic Checks

A has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
There is no outstanding debt for A. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

A has an Altman-Z score of 5.89. This indicates that A is financially healthy and has little risk of bankruptcy at the moment.
A has a Altman-Z score of 5.89. This is amongst the best in the industry. A outperforms 80.36% of its industry peers.
A has a debt to FCF ratio of 2.07. This is a good value and a sign of high solvency as A would need 2.07 years to pay back of all of its debts.
The Debt to FCF ratio of A (2.07) is better than 87.50% of its industry peers.
A Debt/Equity ratio of 0.50 indicates that A is not too dependend on debt financing.
The Debt to Equity ratio of A (0.50) is worse than 62.50% of its industry peers.
Even though the debt/equity ratio score it not favorable for A, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
Industry RankSector Rank
Debt/Equity 0.5
Debt/FCF 2.07
Altman-Z 5.89
ROIC/WACC1.3
WACC11.59%

2.3 Liquidity

A Current Ratio of 1.78 indicates that A should not have too much problems paying its short term obligations.
With a Current ratio value of 1.78, A is not doing good in the industry: 67.86% of the companies in the same industry are doing better.
A Quick Ratio of 1.37 indicates that A should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.37, A is doing worse than 62.50% of the companies in the same industry.
The current and quick ratio evaluation for A is rather negative, while it does have excellent solvency and profitability. These ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 1.78
Quick Ratio 1.37

3

3. Growth

3.1 Past

A shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -2.94%.
Measured over the past years, A shows a quite strong growth in Earnings Per Share. The EPS has been growing by 11.14% on average per year.
EPS 1Y (TTM)-2.94%
EPS 3Y6.82%
EPS 5Y11.14%
EPS Q2Q%5.8%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%0.77%

3.2 Future

A is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.19% yearly.
A is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.68% yearly.
EPS Next Y7.33%
EPS Next 2Y8.66%
EPS Next 3Y9.23%
EPS Next 5Y9.19%
Revenue Next Year5.51%
Revenue Next 2Y5.98%
Revenue Next 3Y6.07%
Revenue Next 5Y5.68%

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.

5

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 25.43, A can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Earnings ratio of A indicates a rather cheap valuation: A is cheaper than 82.14% of the companies listed in the same industry.
A's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.73.
The Price/Forward Earnings ratio is 23.69, which indicates a rather expensive current valuation of A.
Compared to the rest of the industry, the Price/Forward Earnings ratio of A indicates a somewhat cheap valuation: A is cheaper than 78.57% of the companies listed in the same industry.
A's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 22.83.
Industry RankSector Rank
PE 25.43
Fwd PE 23.69

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, A is valued cheaper than 85.71% of the companies in the same industry.
A's Price/Free Cash Flow ratio is rather cheap when compared to the industry. A is cheaper than 82.14% of the companies in the same industry.
Industry RankSector Rank
P/FCF 27.07
EV/EBITDA 20.87

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
A has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)3.47
PEG (5Y)2.28
EPS Next 2Y8.66%
EPS Next 3Y9.23%

5

5. Dividend

5.1 Amount

A has a yearly dividend return of 0.74%, which is pretty low.
Compared to an average industry Dividend Yield of 0.64, A pays a better dividend. On top of this A pays more dividend than 98.21% of the companies listed in the same industry.
With a Dividend Yield of 0.74, A pays less dividend than the S&P500 average, which is at 2.34.
Industry RankSector Rank
Dividend Yield 0.74%

5.2 History

On average, the dividend of A grows each year by 8.62%, which is quite nice.
A has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)8.62%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

19.25% of the earnings are spent on dividend by A. This is a low number and sustainable payout ratio.
The dividend of A is growing around the same rate as the earnings are growing. If this keeps up the dividend growth is sustainable.
DP19.25%
EPS Next 2Y8.66%
EPS Next 3Y9.23%

AGILENT TECHNOLOGIES INC

NYSE:A (12/20/2024, 8:04:00 PM)

After market: 134.51 0 (0%)

134.51

+1.32 (+0.99%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)11-25 2024-11-25/amc
Earnings (Next)N/A N/A
Inst Owners91.99%
Inst Owner Change-1.16%
Ins Owners0.19%
Ins Owner Change1.08%
Market Cap38.36B
Analysts73.33
Price Target151.26 (12.45%)
Short Float %1.01%
Short Ratio1.6
Dividend
Industry RankSector Rank
Dividend Yield 0.74%
Dividend Growth(5Y)8.62%
DP19.25%
Div Incr Years0
Div Non Decr Years0
Ex-Date12-31 2024-12-31 (0.248)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)1.62%
Min EPS beat(2)0.33%
Max EPS beat(2)2.92%
EPS beat(4)4
Avg EPS beat(4)1.87%
Min EPS beat(4)0.33%
Max EPS beat(4)3.38%
EPS beat(8)7
Avg EPS beat(8)2.51%
EPS beat(12)10
Avg EPS beat(12)2.53%
EPS beat(16)14
Avg EPS beat(16)4.62%
Revenue beat(2)0
Avg Revenue beat(2)-1.62%
Min Revenue beat(2)-2.54%
Max Revenue beat(2)-0.69%
Revenue beat(4)1
Avg Revenue beat(4)-0.46%
Min Revenue beat(4)-2.54%
Max Revenue beat(4)2.35%
Revenue beat(8)4
Avg Revenue beat(8)0.28%
Revenue beat(12)5
Avg Revenue beat(12)0.01%
Revenue beat(16)9
Avg Revenue beat(16)1.08%
PT rev (1m)-0.21%
PT rev (3m)2.05%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.11%
EPS NY rev (1m)0%
EPS NY rev (3m)0.03%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.29%
Revenue NY rev (1m)0.02%
Revenue NY rev (3m)0.08%
Valuation
Industry RankSector Rank
PE 25.43
Fwd PE 23.69
P/S 5.9
P/FCF 27.07
P/OCF 21.48
P/B 6.5
P/tB 24.81
EV/EBITDA 20.87
EPS(TTM)5.29
EY3.93%
EPS(NY)5.68
Fwd EY4.22%
FCF(TTM)4.97
FCFY3.69%
OCF(TTM)6.26
OCFY4.66%
SpS22.78
BVpS20.7
TBVpS5.42
PEG (NY)3.47
PEG (5Y)2.28
Profitability
Industry RankSector Rank
ROA 12.85%
ROE 23.94%
ROCE 18.65%
ROIC 15.02%
ROICexc 18.53%
ROICexgc 43.24%
OM 24.7%
PM (TTM) 21.75%
GM 54.75%
FCFM 21.81%
ROA(3y)11.58%
ROA(5y)10.71%
ROE(3y)22.44%
ROE(5y)20.92%
ROIC(3y)14.34%
ROIC(5y)12.54%
ROICexc(3y)16.97%
ROICexc(5y)14.94%
ROICexgc(3y)45.64%
ROICexgc(5y)42.58%
ROCE(3y)16.32%
ROCE(5y)14.48%
ROICexcg growth 3Y7.24%
ROICexcg growth 5Y-3.92%
ROICexc growth 3Y13.69%
ROICexc growth 5Y0.93%
OM growth 3Y8.56%
OM growth 5Y2.16%
PM growth 3Y10.45%
PM growth 5Y23.06%
GM growth 3Y-1.44%
GM growth 5Y-1.41%
F-Score7
Asset Turnover0.59
Health
Industry RankSector Rank
Debt/Equity 0.5
Debt/FCF 2.07
Debt/EBITDA 1.58
Cap/Depr 147.6%
Cap/Sales 5.68%
Interest Coverage 20.32
Cash Conversion 96.28%
Profit Quality 100.28%
Current Ratio 1.78
Quick Ratio 1.37
Altman-Z 5.89
F-Score7
WACC11.59%
ROIC/WACC1.3
Cap/Depr(3y)86.88%
Cap/Depr(5y)72.96%
Cap/Sales(3y)3.87%
Cap/Sales(5y)3.37%
Profit Quality(3y)102.47%
Profit Quality(5y)99.94%
High Growth Momentum
Growth
EPS 1Y (TTM)-2.94%
EPS 3Y6.82%
EPS 5Y11.14%
EPS Q2Q%5.8%
EPS Next Y7.33%
EPS Next 2Y8.66%
EPS Next 3Y9.23%
EPS Next 5Y9.19%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%0.77%
Revenue Next Year5.51%
Revenue Next 2Y5.98%
Revenue Next 3Y6.07%
Revenue Next 5Y5.68%
EBIT growth 1Y12.87%
EBIT growth 3Y17.87%
EBIT growth 5Y9.12%
EBIT Next Year5.04%
EBIT Next 3Y6.36%
EBIT Next 5Y7.13%
FCF growth 1Y38.65%
FCF growth 3Y22.49%
FCF growth 5Y10.13%
OCF growth 1Y36.86%
OCF growth 3Y24.38%
OCF growth 5Y10.27%